Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
Listen wherever you get your podcasts, and subscribe to my Substack to read bonus material.
The primary one is competition from other GLP-1 drugs, especially from Eli Lillys Mounjaro (tirzepatide), which has shown greater efficacy in weight loss and diabetes control
Oral GLP-1 medications generally produce somewhat less weight loss than injectable versions in clinical data (16.6% vs
(Source: Chemist4U) People with a BMI over 45 reported an average life satisfaction score of 5.86/10 , which is about 20% lower than those with a BMI between 30 and 35
Why Weight Loss Medication Is Not Right for Everyone A treatment can be effective in clinical studies and still be difficult for an individual patient to tolerate or maintain
It is for patients with either: A body mass index (BMI) of 30 kg/m2 or greater A BMI of 27 kg/m2 or greater with at least one weight-related ailment such as type 2 diabetes, hypertension, sleep apnea, or others
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
